05:23 PM EST, 02/14/2025 (MT Newswires) -- Ronald E Blaylock, Director, on February 13, 2025, executed a purchase for 19,457 shares in Pfizer ( PFE ) for $499,072. Following the Form 4 filing with the SEC, Blaylock has control over a total of 32,457 common shares of the company, with 27,707 shares held directly and 4,750 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/78003/000122520825001778/xslF345X05/doc4.xml